Response to crizotinib in ROS1-rearranged non-small-cell lung cancer
- PMID: 22891268
- DOI: 10.1200/JCO.2012.42.4556
Response to crizotinib in ROS1-rearranged non-small-cell lung cancer
Comment on
-
ROS1 rearrangements define a unique molecular class of lung cancers.J Clin Oncol. 2012 Mar 10;30(8):863-70. doi: 10.1200/JCO.2011.35.6345. Epub 2012 Jan 3. J Clin Oncol. 2012. PMID: 22215748 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
